Physician profile
Muhammad Ayub
NPI 1710941836
$3,860.51
in general payments reported to CMS, 2019-2025
32 companies · $569 in 2025
The $569 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,557 · 2020: $486 · 2021: $117 · 2022: $26.20 · 2023: $304 · 2024: $800 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $679.11 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $545.46 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Lilly USA, LLC | $373.42 | 2019-2025 | Mounjaro, Zepbound |
| Amgen INC. | $343.08 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $252.94 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $221.44 | 2019-2025 | Gardasil 9, Verquvo, Steglatro |
| Novartis Pharmaceuticals Corporation | $177.78 | 2019-2025 | |
| Amarin Pharma, INC. | $130.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $121.22 | 2019-2024 | Breztri, Farxiga |
| Janssen Pharmaceuticals, INC | $118.34 | 2019-2021 | |
| Boston Scientific Corporation | $116.32 | 2019 | |
| Pfizer INC. | $105.90 | 2019-2024 | |
| Ethicon US, LLC | $93.60 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $86.25 | 2019-2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $83.67 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.18 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $54.65 | 2024-2025 | |
| Exact Sciences Corporation | $31.14 | 2024 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $28.48 | 2019 | |
| Hologic Sales and Service, LLC | $27.17 | 2025 | Aptima |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.56 | 2019 | |
| Sunovion Pharmaceuticals INC. | $21.01 | 2021 | |
| Dynavax Technologies Corporation | $16.37 | 2024 | Heplisav-B |
| Genentech USA, INC. | $16.18 | 2025 | Ocrevus Zunovo |
| Arbor Pharmaceuticals, INC. | $14.89 | 2019 | |
| Astellas Pharma US INC | $14.82 | 2020 | |
| Shionogi INC | $14.74 | 2019 | |
| Daiichi Sankyo INC. | $14.55 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.29 | 2019 | |
| Gilead Sciences, INC. | $12.75 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.65 | 2019 | |
| Hikma Pharmaceuticals USA | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ayub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.